BAT Stock Drops 1.2% Ending Six-Day Rally

BAT by 2FIRSTS.ai
Jan.10.2024
BAT Stock Drops 1.2% Ending Six-Day Rally
BAT stock ends six-day rising streak, decreasing by 1.2% to $30.20. Despite recent gains, overall stock dropped 24% in past year.

According to a report from Seekingalpha, the share price of British American Tobacco (BAT) ended its six-day upward trend on January 9th, experiencing a 1.2% drop during afternoon trading and closing at a price of $30.20.

 

The company's stock price has risen by approximately 4.3% over the past six trading days. However, overall, the company's stock price has dropped by 24% in the past year, contrasting with the broader S&P 500 index which has seen a 22% increase. On January 8th, the company's shares closed at $30.57, marking a 0.9% increase. For British American Tobacco, the performance in December was mixed, with 11 trading days showing an increase and 9 trading days experiencing a decline.

 

Among the analysts on Wall Street, three have strongly recommended buying stocks of BAT, while one has given a buy recommendation. One analyst has suggested holding the stock, while no one has recommended selling or strongly selling it.

 

Earlier last month, the company made a $31.5 billion write-down on the value of its American cigarette brands, which sent shockwaves through the investor community. While some analysts view this as a buying opportunity, analysis reveals concerns among people regarding potential additional expenses that other tobacco companies might incur as a result of BAT's recent write-down.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
Sesh said its Premarket Tobacco Product Application (PMTA) for 64 nicotine pouch SKUs has been accepted by the U.S. Food and Drug Administration (FDA) and advanced to the Filing stage, entering substantive scientific review. Industry experts say the development signals that the application has crossed a key technical and regulatory threshold, while also highlighting growing divergence in regulatory capability and market positioning within the nicotine pouch category.
Special Report
Mar.24 by 2FIRSTS.ai
Exclusive: Glas says FDA-authorized G2 vape includes age-gating technology
Exclusive: Glas says FDA-authorized G2 vape includes age-gating technology
Glas has confirmed to 2Firsts that its G2 device, which received a FDA Marketing Granted Order (MGO), incorporates age-gating technology. Based on currently public information, this means the FDA has granted an MGO to the first ENDS product confirmed to incorporate age-gating technology, validating 2Firsts’ earlier inference.
Mar.17
Australia’s Tasmania Tables New Bill to Strengthen Crackdown on Illicit Tobacco and Vapes
Australia’s Tasmania Tables New Bill to Strengthen Crackdown on Illicit Tobacco and Vapes
The Tasmanian government has tabled the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026 in Parliament, proposing new offences, higher penalties and stronger enforcement powers to crack down on illicit tobacco and vaping products.
Mar.25 by 2FIRSTS.ai
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
Swedish Government Minister Visits Nicotine Pouch Factory, Calls Sector Important Export Industry
Swedish Government Minister Visits Nicotine Pouch Factory, Calls Sector Important Export Industry
Sweden’s Minister for Foreign Trade and Development Cooperation, Benjamin Dousa, visited nicotine pouch producer Another Snus Factory on Monday, calling the sector an important export industry as several European countries tighten regulation of the products.The company produces about 30 million cans of white snus annually and holds roughly 12% of Sweden’s domestic market.
Apr.16